Latvian
Albanian
Arabic
Armenian
Azerbaijani
Belarusian
Bengali
Bosnian
Catalan
Czech
Danish
Deutsch
Dutch
English
Estonian
Finnish
Français
Greek
Haitian Creole
Hebrew
Hindi
Hungarian
Icelandic
Indonesian
Irish
Italian
Japanese
Korean
Latvian
Lithuanian
Macedonian
Mongolian
Norwegian
Persian
Polish
Portuguese
Romanian
Russian
Serbian
Slovak
Slovenian
Spanish
Swahili
Swedish
Turkish
Ukrainian
Vietnamese
Български
中文(简体)
中文(繁體)

chymotrypsin/asiņošana

Saite tiek saglabāta starpliktuvē
Lappuse 1 no 19 rezultātiem

Heterocyclic protease inhibitors

Rakstu tulkošanu var veikt tikai reģistrēti lietotāji
Ielogoties Reģistrēties
BACKGROUND OF THE INVENTION 1. Field of the Invention The present invention relates to novel compounds that function as proteolytic enzyme inhibitors, and particularly to a new class of thrombin inhibitors. 2. Related Art Proteases are enzymes that cleave proteins at single, specific peptide bonds.

Cyclic oxyguanidine protease inhibitors

Rakstu tulkošanu var veikt tikai reģistrēti lietotāji
Ielogoties Reģistrēties
BACKGROUND OF THE INVENTION 1. Field of the Invention The present invention relates to novel compounds that function as enzyme inhibitors, and particularly to a new class of non-peptidic inhibitors of proteolytic enzymes. 2. Background Art Proteases are enzymes that cleave proteins at single,

Cyclic oxyguanidine pyrazinones as protease inhibitors

Rakstu tulkošanu var veikt tikai reģistrēti lietotāji
Ielogoties Reģistrēties
BACKGROUND OF THE INVENTION 1. Field of the Invention The present invention relates to novel compounds that function as proteolytic enzyme inhibitors, and particularly to a new class of thrombin inhibitors. 2. Background Art Proteases are enzymes that cleave proteins at single, specific peptide

Cyclic oxyguanidine pyrazinones as protease inhibitors

Rakstu tulkošanu var veikt tikai reģistrēti lietotāji
Ielogoties Reģistrēties
BACKGROUND OF THE INVENTION 1. Field of the Invention The present invention relates to novel compounds that function as proteolytic enzyme inhibitors, and particularly to a new class of thrombin inhibitors. 2. Background Art Proteases are enzymes that cleave proteins at single, specific peptide

Thromboresistant materials incorporating pyrazinone protease inhibitors

Rakstu tulkošanu var veikt tikai reģistrēti lietotāji
Ielogoties Reģistrēties
BACKGROUND OF THE INVENTION 1. Field of the Invention The present invention relates to novel compounds that function as proteolytic enzyme inhibitors, and particularly to a new class of thrombin inhibitors. 2. Related Art Proteases are enzymes that cleave proteins at single, specific peptide bonds.

Aminoguanidines and alkoxyguanidines as protease inhibitors

Rakstu tulkošanu var veikt tikai reģistrēti lietotāji
Ielogoties Reģistrēties
BACKGROUND OF THE INVENTION 1. Field of the Invention The present invention relates to novel compounds that function as enzyme inhibitors, and particularly to a new class of non-peptide inhibitors of proteolytic enzymes. 2. Related Art Proteases are enzymes that cleave proteins at single, specific

Aminoguanidines and alkoxyguanidines as protease inhibitors

Rakstu tulkošanu var veikt tikai reģistrēti lietotāji
Ielogoties Reģistrēties
BACKGROUND OF THE INVENTION 1. Field of the Invention The present invention relates to novel compounds that finction as enzyme inhibitors, and particularly to a new class of non-peptidic inhibitors of proteolytic enzymes. 2. Related Art Proteases are enzymes that cleave proteins at single, specific

Aminoguanidines and alkoxyguanidines as protease inhibitors

Rakstu tulkošanu var veikt tikai reģistrēti lietotāji
Ielogoties Reģistrēties
BACKGROUND OF THE INVENTION 1. Field of the Invention The present invention relates to novel compounds that function as enzyme inhibitors, and particularly to a new class of non-peptidic inhibitors of proteolytic enzymes. 2. Related Art Proteases are enzymes that cleave proteins at single, specific

Aminoguanidines and alkoxyguanidines as protease inhibitors

Rakstu tulkošanu var veikt tikai reģistrēti lietotāji
Ielogoties Reģistrēties
BACKGROUND OF THE INVENTION 1. Field of the Invention The present invention relates to novel compounds that function as enzyme inhibitors, and particularly to a new class of non-peptidic inhibitors of proteolytic enzymes. 2. Related Art Proteases are enzymes that cleave proteins at single, specific

Heteroaryl protease inhibitors and diagnostic imaging agents

Rakstu tulkošanu var veikt tikai reģistrēti lietotāji
Ielogoties Reģistrēties
BACKGROUND OF THE INVENTION 1. Field of the Invention The present invention relates to novel compounds that function as proteolytic enzyme inhibitors and to their use as diagnostic imaging agents. 2. Related Art Proteases are enzymes that cleave proteins at single, specific peptide bonds. Proteases

Process for preparing aminoguanidines and alkoxyguanidines as protease inhibitors

Rakstu tulkošanu var veikt tikai reģistrēti lietotāji
Ielogoties Reģistrēties
BACKGROUND OF THE INVENTION 1. Field of the Invention The present invention relates to novel compounds that function as enzyme inhibitors, and particularly to a new class of non-peptidic inhibitors of proteolytic enzymes. 2. Related Art Proteases are enzymes that cleave proteins at single, specific

Heteroaryl aminoguanidines and alkoxyguanidines and their use as protease inhibitors

Rakstu tulkošanu var veikt tikai reģistrēti lietotāji
Ielogoties Reģistrēties
BACKGROUND OF THE INVENTION 1. Field of the Invention The present invention relates to novel compounds that function as proteolytic enzyme inhibitors, and particularly to a new class of thrombin inhibitors. 2. Related Art Proteases are enzymes that cleave proteins at single, specific peptide bonds.

Heteroaryl aminoguanidines and alkoxyguanidines and their use as protease inhibitors

Rakstu tulkošanu var veikt tikai reģistrēti lietotāji
Ielogoties Reģistrēties
BACKGROUND OF THE INVENTION 1. Field of the Invention The present invention relates to novel compounds that function as proteolytic enzyme inhibitors, and particularly to a new class of thrombin inhibitors. 2. Related Art Proteases are enzymes that cleave proteins at single, specific peptide bonds.

Heteroaryl aminoguanidines and alkoxyguanidines and their use as protease inhibitors

Rakstu tulkošanu var veikt tikai reģistrēti lietotāji
Ielogoties Reģistrēties
BACKGROUND OF THE INVENTION 1. Field of the Invention The present invention relates to novel compounds that function as proteolytic enzyme inhibitors, and particularly to a new class of thrombin inhibitors. 2. Related Art Proteases are enzymes that cleave proteins at single, specific peptide bonds.

Heteroaryl aminoguanidines and alkoxyguanidines and their use as protease inhibitors

Rakstu tulkošanu var veikt tikai reģistrēti lietotāji
Ielogoties Reģistrēties
BACKGROUND OF THE INVENTION 1. Field of the Invention The present invention relates to novel compounds that function as proteolytic enzyme inhibitors, and particularly to a new class of thrombin inhibitors. 2. Related Art Proteases are enzymes that cleave proteins at single, specific peptide bonds.
Pievienojieties mūsu
facebook lapai

Vispilnīgākā ārstniecības augu datu bāze, kuru atbalsta zinātne

  • Darbojas 55 valodās
  • Zāļu ārstniecības līdzekļi, kurus atbalsta zinātne
  • Garšaugu atpazīšana pēc attēla
  • Interaktīva GPS karte - atzīmējiet garšaugus atrašanās vietā (drīzumā)
  • Lasiet zinātniskās publikācijas, kas saistītas ar jūsu meklēšanu
  • Meklēt ārstniecības augus pēc to iedarbības
  • Organizējiet savas intereses un sekojiet līdzi jaunumiem, klīniskajiem izmēģinājumiem un patentiem

Ierakstiet simptomu vai slimību un izlasiet par garšaugiem, kas varētu palīdzēt, ierakstiet zāli un redziet slimības un simptomus, pret kuriem tā tiek lietota.
* Visa informācija ir balstīta uz publicētiem zinātniskiem pētījumiem

Google Play badgeApp Store badge